Published in In Vitro on January 01, 1977
Colony size distributions as a measure of in vivo and in vitro aging. Proc Natl Acad Sci U S A (1978) 1.27
Diabetes mellitus and genetic prediabetes. Decreased replicative capacity of cultured skin fibroblasts. J Clin Invest (1979) 1.01
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med (2000) 18.12
Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol (1983) 5.05
HEMOGLOBIN AND PLASMA PROTEIN : SIMULTANEOUS PRODUCTION DURING CONTINUED BLEEDING AS INFLUENCED BY AMINO ACIDS, PLASMA, HEMOGLOBIN, AND DIGESTS OF SERUM, HEMOGLOBIN, AND CASEIN. J Exp Med (1943) 4.18
Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci U S A (1984) 3.22
TEN AMINO ACIDS ESSENTIAL FOR PLASMA PROTEIN PRODUCTION EFFECTIVE ORALLY OR INTRAVENOUSLY. J Exp Med (1943) 2.91
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group. J Clin Oncol (2000) 2.73
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med (1997) 2.25
Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol (1999) 2.23
CASEIN DIGESTS PARENTERALLY UTILIZED TO FORM BLOOD PLASMA PROTEIN. J Exp Med (1941) 2.18
The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem (1988) 2.15
Clonal growth of normal human epidermal keratinocytes in a defined medium. J Cell Physiol (1982) 2.05
Selenium is an essential trace nutrient for growth of WI-38 diploid human fibroblasts. Proc Natl Acad Sci U S A (1976) 1.98
Improved medium and culture conditions for clonal growth with minimal serum protein and for enhanced serum-free survival of Swiss 3T3 cells. In Vitro (1981) 1.89
Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients. Drug Metab Dispos (2000) 1.67
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J (2011) 1.63
PLASMA SUBSTITUTES : HUMAN AND ANIMAL GLOBIN RELATED TO THE PRODUCTION OF HEMOGLOBIN AND PLASMA PROTEIN DOG HEMOGLOBIN UTILIZATION IMPROVED BY METHIONINE BUT NOT BY ISOLEUCINE. J Exp Med (1946) 1.61
PERITONEAL ABSORPTION : RED CELLS LABELED BY RADIO-IRON HEMOGLOBIN MOVE PROMPTLY FROM PERITONEAL CAVITY INTO THE CIRCULATION. J Exp Med (1944) 1.55
Improved medium for clonal growth of human diploid fibroblasts at low concentrations of serum protein. In Vitro (1977) 1.47
Media and growth requirements. Methods Enzymol (1979) 1.47
HEMOGLOBIN AND PLASMA PROTEIN PRODUCTION : VARIOUS PROTEINS, CONCENTRATES, AND DIGESTS INFLUENCE BLOOD PROTEIN PRODUCTION IN ANEMIA AND HYPOPROTEINEMIA. J Exp Med (1946) 1.46
Calcium and magnesium ions and the regulation of multiplication in normal and transformed cells. Nature (1978) 1.46
Digital vasculitis associated with interferon therapy. Am J Med (1992) 1.45
Thermal injury and recovery of Bacillus subtilis. Appl Microbiol (1972) 1.45
Clonal growth of human keratinocytes with small amounts of dialyzed serum. In Vitro (1980) 1.41
A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma. Cancer (1999) 1.41
RAIDING OF BODY TISSUE PROTEIN TO FORM PLASMA PROTEIN AND HEMOGLOBIN : WHAT IS PREMORTAL RISE OF URINARY NITROGEN? J Exp Med (1947) 1.40
Stopping a clinical trial very early because of toxicity: summarizing the evidence. Control Clin Trials (1993) 1.39
Putrescine and related amines as growth factors for a mammalian cell line. Biochem Biophys Res Commun (1964) 1.39
The gatekeeping funnel: tracking a major PSA campaign from distribution through gatekeepers to target audience. Health Educ Q (1987) 1.35
PLASMA PROTEIN AND HEMOGLOBIN PRODUCTION : DELETION OF INDIVIDUAL AMINO ACIDS FROM GROWTH MIXTURE OF TEN ESSENTIAL AMINO ACIDS. SIGNIFICANT CHANGES IN URINARY NITROGEN. J Exp Med (1947) 1.34
Growth and differentiation of human keratinocytes without a feeder layer or conditioned medium. In Vitro (1980) 1.33
Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard. Oncologist (2001) 1.29
PLASMA PROTEIN PRODUCTION AS INFLUENCED BY PARENTERAL PROTEIN DIGESTS, VERY HIGH PROTEIN FEEDING, AND RED BLOOD CELL CATABOLISM. J Exp Med (1945) 1.22
Cannabis: effects on memory and the cholinergic limbic system. Psychol Bull (1983) 1.19
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Cancer Res (1987) 1.18
The effect of perfusate pH on glutamine metabolism in the isolated perfused rat liver. J Biol Chem (1970) 1.18
The functional significance of changes in activity of the enzymes, tryptophan pyrrolase and tyrosine transaminase, after induction in intact rats and in the isolated, perfused rat liver. J Biol Chem (1969) 1.14
A CASEIN DIGEST BY VEIN UTILIZED TO FORM BLOOD PLASMA PROTEIN. Science (1941) 1.12
Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes. Biochem J (1989) 1.11
Optimized medium for clonal growth of human microvascular endothelial cells with minimal serum. In Vitro Cell Dev Biol (1987) 1.10
Stimulation of clonal growth of normal fibroblasts with substrata coated with basic polymers. J Cell Biol (1976) 1.10
Effect of whole x-irradiation of rats on net synthesis of albumin, fibrinogen, alpha-1-acid glycoprotein, and alpha-2-globulin (acute phase globulin) by the isolated, perfused rat liver. J Biol Chem (1968) 1.08
Dermal fibroblasts. Methods Cell Biol (1980) 1.07
Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. J Biol Chem (1991) 1.06
Infraputaminal 'lacunes'. Clinical and pathological correlations. Stroke (1995) 1.06
The PREP system of nursing interventions: a pilot test with families caring for older members. Preparedness (PR), enrichment (E) and predictability (P). Res Nurs Health (1995) 1.06
Measurement of pepsin I (gastricsin) in human gastric juice. Gastroenterology (1967) 1.06
Clonal growth of chinese hamster cell lines in protein-free media. In Vitro (1977) 1.05
Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry (1983) 1.04
Methods for reducing the serum requirement for growth in vitro of nontransformed diploid fibroblasts. Dev Biol Stand (1978) 1.03
Rapid clonal growth and serial passage of human diploid fibroblasts in a lipid-enriched synthetic medium supplemented with epidermal growth factor, insulin, and dexamethasone. Proc Natl Acad Sci U S A (1981) 1.03
Influence of actinomycin D and puromycin on net synthesis of plasma albumin and fibrinogen by the isolated perfused rat liver. J Biol Chem (1966) 1.02
Missing quasiparticles and the chemical potential puzzle in the doping evolution of the cuprate superconductors. Phys Rev Lett (2004) 1.02
A comparison of measures of reading and intelligence as risk factors for the development of myopia in a UK cohort of children. Br J Ophthalmol (2008) 1.00
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy. Clin Cancer Res (2000) 1.00
Response of serum cytokines in patients undergoing laparoscopic cholecystectomy. Surg Endosc (1994) 0.99
Studies of human intrinsic factor auto-antibodies. J Immunol (1966) 0.96
Genome-wide association study of shared components of reading disability and language impairment. Genes Brain Behav (2013) 0.95
Studies on the heterogeneity of human gastric zymogens. Biochem J (1970) 0.95
Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors. J Clin Oncol (1999) 0.95
Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine. J Natl Cancer Inst (1992) 0.94
Improved medium with EGF and BSA for differentiated human skeletal muscle cells. Muscle Nerve (1992) 0.93
Synthesis of clotting factors by the isolated perfused rat liver. J Clin Invest (1966) 0.93
Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J Natl Cancer Inst (1992) 0.92
Cerebellomedullary ganglioglioma: CT and MR findings. AJNR Am J Neuroradiol (1995) 0.92
Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology (1979) 0.92
Clonal growth of differentiated rabbit cartilage cells. J Cell Physiol (1968) 0.91
Multiplication of Swiss 3T3 cells in a serum-free medium. Exp Cell Res (1983) 0.91
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks. Ann Oncol (2001) 0.91
Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry (1983) 0.90
Assay and partial purification of factors from serum that control multiplication of human diploid fibroblasts. Biochem Biophys Res Commun (1978) 0.90
The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. J Clin Oncol (1992) 0.90
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol (1999) 0.89
Spontaneous palpebromandibular synkinesia: a localizing clinical sign. Ann Neurol (1994) 0.89
Growth and adipose differentiation of sheep preadipocyte fibroblasts in serum-free medium. Eur J Biochem (1983) 0.88
Multiplication of human diploid fibroblasts in a synthetic medium supplemented with EGF, insulin, and dexamethasone. Exp Cell Res (1981) 0.88
Development of improved media and culture conditions for clonal growth of normal diploid cells. In Vitro (1978) 0.88
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma. Ann Oncol (2001) 0.88
Effect of 9 -THC on the open-field activity of the rat. Psychopharmacologia (1972) 0.88
Marijuana and memory impairment: effect on free recall and recognition memory. Pharmacol Biochem Behav (1977) 0.87
Caries-preventive effects of sodium and amine fluoride dentifrices. Am J Dent (1999) 0.87
Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. Am J Pathol (1995) 0.86
GELATIN-ITS USEFULNESS AND TOXICITY : BLOOD PROTEIN PRODUCTION IMPAIRED BY CONTINUED GELATIN BY VEIN. J Exp Med (1944) 0.86
Supra-aortic arterial stenoses: management with Palmaz balloon-expandable intraluminal stents. J Vasc Interv Radiol (1997) 0.86
Pepstatin-insensitive proteolytic activity of rat liver lysosomes. Isolation and purification of a new pepstatin-insensitive proteolytic enzyme from rat liver lysosomes. J Biol Chem (1977) 0.85
Expression of adhesion molecules in cultured human pulmonary microvascular endothelial cells. Microvasc Res (1995) 0.85
Effect of aging on animal response to chronic fluoride exposure. J Dent Res (1995) 0.84
Pathology of small artery disease. Adv Neurol (1993) 0.84
Biosynthesis of substance P in cultured mouse neuroblastoma and rat glioma cells. Brain Res (1978) 0.84
Relationship between plasma delta-9-tetrahydrocannabinol concentration and pharmacologic effects in man. Psychopharmacology (Berl) (1981) 0.84
Nutritional requirements of primary cultures. a neglected problem of modern biology. In Vitro (1977) 0.84
Protein-free medium for C-1300 mouse neuroblastoma cells. In Vitro (1981) 0.83
Effect of aflatoxin B1 on net synthesis of albumin, fibrinogen, and alpha-1-acid glycoprotein by the isolated perfused rat liver. Biochem Pharmacol (1969) 0.83
Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol (1995) 0.83
Marijuana: effects on free recall and subjective organization of pictures and words. Psychopharmacology (Berl) (1977) 0.82